Earnest John Drugs And Chemicals Private Limited - Company Profile

It is a engineering private limited company based in Mumbai, Maharashtra, India, established in 1992.
1992 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Earnest John Drugs And Chemicals Private Limited

Earnest John Drugs And Chemicals Private Limited, a active private limited company, was established on 09 July 1992 in Mumbai, Maharashtra, India. Engaging in industrial maintenance & repair services within the engineering sector, it holds CIN: U24219MH1992PTC067617. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹2.83 Cr.

It upholds a compliant status. Its leadership includes Dean Christopher John (Director), Chloris Josephine John (Whole-Time Director), Doris John Lourdes (Director). Past directors included Dean Christopher John. It holds no open charges and ₹6.25 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Room No 107,10Th Floor, Earnest House,194 Nariman Point, Mumbai, Maharashtra, 400021.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24219MH1992PTC067617

  • Registration Number

    067617

  • Incorporation Date

    09 July 1992

  • Authorized Capital

    ₹3.00 Cr

  • Paid-Up Capital

    ₹2.83 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 Cr
  • Paid Up Capital ₹ 2.83 Cr
  • Company Age 33 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 6.25 Cr
  • Revenue Growth **** 96.21%
  • Profit Growth **** 34.49%
  • Ebitda **** 61.26%
  • Net Worth -0.99%
  • Total Assets -0.07%
Company report

Earnest John Drugs And Chemicals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Earnest John Drugs And Chemicals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Earnest John Drugs And Chemicals Private Limited?
Current Directors
Name Designation Appointment Date Status
Dean Christopher John Director 01 Jun 2012 Current
Chloris Josephine John Whole-Time Director 01 Apr 2003 Current
Doris John Lourdes Director 25 Sep 1996 Current
Earnest Joseph John Director 19 Sep 1997 Current
Christopher John Joseph Director 29 Sep 1995 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 24 Sep 2012 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Earnest John Drugs And Chemicals.

Earnest John Drugs And Chemicals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 96.21% increase. The company also saw a substantial improvement in profitability, with a 34.49% increase in profit. The company's net worth dipped by a decrease of 0.99%.

Earnest John Drugs And Chemicals revenue growth over time
Earnest John Drugs And Chemicals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 96.21%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -0.07%
*******
*******
*******
*******
Profit or Loss
*******
 34.49%
*******
*******
*******
*******
Net Worth
*******
 -0.99%
*******
*******
*******
*******
EBITDA
*******
 61.26%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Earnest John Drugs And Chemicals?

In 2020, Earnest John Drugs And Chemicals had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹62,475,000.00

Charges Breakdown by Lending Institutions
  • Corporation Bank : 5.75 Cr
  • The Maharashtra State Financial Corp. : 0.50 Cr
Latest Charge Details
Date Lender Amount Status
17 Mar 2003 Corporation Bank ₹5.75 Cr Satisfied
30 Sep 1993 The Maharashtra State Financial Corp. ₹4.98 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Earnest John Drugs And Chemicals?

Unlock and access historical data on people associated with Earnest John Drugs And Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Earnest John Drugs And Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Earnest John Drugs And Chemicals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Earnest John Drugs And Chemicals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Earnest John Drugs And Chemicals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Earnest John Drugs And Chemicals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    Progress on Dean Christopher John was appointed as a Director was appointed as a Director on 01 Jun 2012 & has been associated with this company since 13 years 8 months . was documented.

  • Charges

    The activity A charge registered on 17 Mar 2003 via Charge ID 90164340 with Corporation Bank was fully satisfied on 12 Aug 2008. was completed.

  • Director Appointment

    Progress on Chloris Josephine John was appointed as a Whole-time director was appointed as a Whole-time director on 01 Apr 2003 & has been associated with this company since 22 years 11 months . was documented.

  • Charges

    A charge with Corporation Bank amounted to Rs. 5.75 Cr with Charge ID 90164340 was registered on 17 Mar 2003. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Earnest John Drugs And Chemicals Private Limited?

The CIN of Earnest John Drugs And Chemicals Private Limited is U24219MH1992PTC067617.

Where is Earnest John Drugs And Chemicals Private Limited headquartered?

Earnest John Drugs And Chemicals Private Limited is headquartered at Room No 107,10Th Floor, Earnest House,194 Nariman Point, Mumbai, Maharashtra, 400021.

When was Earnest John Drugs And Chemicals Private Limited incorporated?

Earnest John Drugs And Chemicals Private Limited was incorporated on 09 July 1992.

Who are the current directors of Earnest John Drugs And Chemicals Private Limited?

The current directors of Earnest John Drugs And Chemicals Private Limited are

What is the primary industry of Earnest John Drugs And Chemicals Private Limited?

The primary industry of Earnest John Drugs And Chemicals Private Limited is Engineering.

Is Earnest John Drugs And Chemicals Private Limited a listed company?

Earnest John Drugs And Chemicals Private Limited is unlisted.

What is the capital structure of Earnest John Drugs And Chemicals Private Limited?

The authorized capital of Earnest John Drugs And Chemicals Private Limited is ₹3.00 Cr, and the paid-up capital is ₹2.83 Cr.

What is the compliance status of Earnest John Drugs And Chemicals Private Limited?

The compliance status of Earnest John Drugs And Chemicals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available